← All trials
NCT05177991
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2022
- Primary completion
- Dec 31, 2024
- Completion date
- Dec 31, 2024
- First posted
- Jan 5, 2022
- Last posted
- Oct 31, 2023
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Our Lady of the Lake Regional Medical CenterLead sponsor
- Our Lady of the Lake Regional Medical CenterCollaborator
- Our Lady of the Lake Regional Medical CenterSponsor investigator
- Our Lady of the Lake Regional Medical CenterStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.